Viewing Study NCT00006033


Ignite Creation Date: 2025-12-25 @ 2:44 AM
Ignite Modification Date: 2026-02-28 @ 8:47 PM
Study NCT ID: NCT00006033
Status: COMPLETED
Last Update Posted: 2013-05-30
First Post: 2000-07-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module